Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Apr 14, 2016; 22(14): 3821-3828
Published online Apr 14, 2016. doi: 10.3748/wjg.v22.i14.3821
Table 1 General characteristics, comorbidities, and preoperative lab tests n (%)
EEN + PN (n = 87)TPN (n = 253)P value
Sex (male)43 (49.4)155 (61.3)0.053
Age (yr)58 ± 1.558 ± 0.70.757
Smoking pack-years (≥ 20)11 (12.6)27 (10.7)0.724
Alcoholic abuse8 (9.2)41 (16.2)0.273
BMI25.8 ± 4.925.5 ± 5.30.845
Body weight loss (n)
> 10%27 (31.0)86 (34.0)0.426
Comorbidities
CAD5 (5.7)14 (5.5)0.975
Hypertension16 (18.4)43 (17.0)0.745
Diabetes mellitus9 (10.3)25 (9.9)0.838
COPD3 (7.0)14 (5.5)0.247
ASA classification ≥ 353 (60.9)149 (58.9)0.461
Hemoglobin (g/L)118.3 ± 1.8121.0 ± 1.00.194
Leukocytes (× 109/L)7.0 ± 0.36.6 ± 0.20.227
Platelet (× 109/L)217.8 ± 7.9206.1 ± 5.00.224
Total bilirubin (μmol/L)147.1 ± 16.3144.6 ± 8.60.882
Alanine aminotransferase (U/L)144.8 ± 14.7151.5 ± 10.80.741
Aspartate aminotransferase (U/L)122.2 ± 12.6130.7 ± 10.80.622
Albumin (ng/mL)43.7 ± 7.339.0 ± 1.60.345
Prothrombin time (s)12.6 ± 0.112.8 ± 0.10.274
Fibronectin4.5 ± 0.14.3 ± 0.10.253
Carcinoembryonic antigen (U/mL)12.8 ± 1.93.7 ± 0.20.960
CA-125 (U/mL)22.6 ± 2.226.5 ± 3.70.516
CA19-9 (U/mL)657.4 ± 197.8844.3 ± 236.30.645